Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?
On 15 May, 2023 By admin 0 Comments
Vaccines
The Vaccine Efficacy Illusion Revisited
On 7 May, 2023 By admin 0 Comments
A review of neurological side effects of COVID-19 vaccination
On 25 Feb, 2023 By admin 0 Comments
February, 2023
Abstract
Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials
On 23 Jun, 2022 By admin 0 Comments
June, 2022
Abstract
Introduction: In 2020, prior to COVID-19 vaccine rollout, the Coalition for Epidemic Preparedness Innovations and Brighton Collaboration created a priority list, endorsed by the World Health Organization, of potential adverse events relevant to COVID-19 vaccines. We leveraged the Brighton Collaboration list to evaluate serious adverse events of special interest observed in phase III randomized trials of mRNA COVID-19 vaccines.
C19 Vax Strategy: Geert Vanden Bossche and Robert Malone, MD
On 19 May, 2022 By admin 0 Comments
Innate Immune Suppression by SARS-CoV-2 mRNA Vaccinations: The role of G-quadruplexes, exosomes and microRNAs
On 7 May, 2022 By admin 0 Comments
January, 2022
Highlights
• mRNA vaccines promote sustained synthesis of the SARS-CoV-2 spike protein.
• The spike protein is neurotoxic, and it impairs DNA repair mechanisms.
• Suppression of type I interferon responses results in impaired innate immunity.
• The mRNA vaccines potentially cause increased risk to infectious diseases and cancer.
• Codon optimization results in G-rich mRNA that has unpredictable complex effects.
Abstract
Immune imprinting, breadth of variant recognition and germinal center response in human SARS-CoV-2 infection and vaccination
On 6 May, 2022 By admin 0 Comments
January, 2022
Highlights
• Vaccination confers broader IgG binding of variant RBDs than SARS-CoV-2 infection
• Imprinting from initial antigen exposures alters IgG responses to viral variants
• Histology of mRNA vaccinee lymph nodes shows abundant germinal centers
• Vaccine spike antigen and mRNA persist for weeks in lymph node germinal centers
Abstract
Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial
On 21 Apr, 2022 By admin 0 Comments
April, 2022
Key Points
Question: Does prior mRNA-1273 vaccination influence anti-nucleocapsid antibody seroconversion and/or seroreversion after SARS-CoV-2 infection?
Randomised Clinical Trials of COVID-19 Vaccines: Do Adenovirus-Vector Vaccines Have Beneficial Non-Specific Effects?
On 6 Apr, 2022 By admin 0 Comments
How Many People Died from the Covid-19 Inoculations? An Estimate Based on a Survey of the United States Population
On 16 Mar, 2022 By admin 0 Comments